iVIZIA Dry Eye

povidone · POVIDONE 25 mg/5mL · Solution/ Drops · Ophthalmic · Thea Pharma Inc.

NDC 82584-0700-05 · 1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. A Class II recall hit this product in the past year (Thea Pharma, Inc.).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application: M018
TE code: —
Approval date: —
Patents / exclusivity: None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

Class II · OngoingApr 23, 2026
Thea Pharma, Inc. — Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.

Manufacturers of povidone (Solution/ Drops)

Labeler	Strength	First seen	Last seen
Thea Pharma Inc.	POVIDONE 25 mg/5mL	Jul 15, 2026	Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "iVIZIA Dry Eye — NDC 82584-0700-05," retrieved September 3, 2026, https://drugdashboards.com/drug/82584070005.

Free to cite with attribution — see how the data is put together.